This site uses cookies to improve your experience.

We use necessary cookies to make our site work. We would also like to set optional analytics cookies to help us improve our site by anonymously collecting and reporting information on how you use it. For more information on how these cookies work, please see our Cookie policy.

Vision Fund investment portfolio company Recursion's logo

Recursion Pharmaceuticals is using AI to accelerate the precision design and development of transformational medicines.

Leadership
Chris Gibson
Fund
SVF2
Status
NASDAQ: RXRX
Sector
Health Tech
Region
Americas